Research has shown that consumer comprehension improves with the US Food and Drug Administration's new bulleted format including icons on the labelling of over-the-counter medicines, the first of a series of FDA and Nonprescription Drug Manufacturers Association meetings heard.
The NDMA said text simplifications can increase consumer understanding, and presented proposals that would reduce the number of words in the pregnancy/nursing and drug interaction warnings by 20%-50%. The association also offered simplified general warning language for OTC antacids, bronchodilators, nasal decongestants and antitussives. The proposed warnings would use bullets to focus consumer attention on key information.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze